Quantcast

Latest seizures Stories

2014-07-23 16:26:38

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Neonatal Seizures Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243633/Neonatal-Seizures-Global-Clinical-Trials-Review-H2-2014.htmlNeonatal Seizures Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Neonatal Seizures Global Clinical Trials Review, H2, 2014" provides data on the Neonatal Seizures clinical trial scenario. This report...

2014-07-23 12:32:31

LONDON, July 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Generalized Seizures Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/2243626/Generalized-Seizures-Global-Clinical-Trials-Review-H2-2014.htmlGeneralized Seizures Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Generalized Seizures Global Clinical Trials Review, H2, 2014" provides data on the Generalized Seizures clinical trial...

2014-07-17 16:20:33

Attribute to Susan Axelrod, Founding Chair, Citizens United for Research in Epilepsy (CURE) CHICAGO, July 17, 2014 /PRNewswire-USNewswire/ -- "CURE applauds the announcement today from the U.S. Department of Defense - allocating $7.5 million dedicated to epilepsy research - and thanks Senator Dick Durbin (D-IL) for his leadership on this issue. The incidence of epilepsy increased by an alarming 52 percent from 2006 to 2010, with approximately 8 percent of those afflicted having been...

2014-07-14 08:27:51

Authorized Generic Topiramate Extended-Release Capsules Available Nationwide MAPLE GROVE, Minn., July 14, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced the launch of Topiramate Extended-Release Capsules, the authorized generic of the recently Food and Drug Administration (FDA) approved Qudexy(TM) XR (topiramate) extended-release capsules, a once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth pharmacokinetic (PK)...

2014-07-03 12:09:17

The JAMA Network Journals Bottom Line: A clinical trial found a reduction in seizures and improvement in related symptoms, including depression and anxiety, in patients with psychogenic nonepileptic seizures (PNES) who were treated with cognitive behavioral therapy informed psychotherapy (CBT-ip) with and without the medication sertraline. Authors: W. Curt LaFrance, Jr., M.D., M.P.H., of Brown University, Rhode Island Hospital, Providence, R.I., and colleagues. Background: PNES is...

2014-07-03 11:54:27

Lifespan New treatment manual targets psychogenic nonepileptic seizures A new study led by a Rhode Island Hospital researcher has found that a cognitive behavior therapy-informed psychotherapy significantly reduces the seizures in patients with psychogenic nonepileptic seizures (PNES), a conversion disorder present worldwide and that affects up to 400,000 people in the U.S. The study led by W. Curt LaFrance Jr., M.D., M.P.H., director of neuropsychiatry and behavioral neurology at...

2014-06-30 12:26:21

LONDON, June 30, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Seizures - Pipeline Review, H1 2014http://www.reportbuyer.com/pharma_healthcare/therapeutic/seizures_pipeline_review_h1_2013.html Seizures - Pipeline Review, H1 2014 SummaryGlobal Markets Direct's, 'Seizures - Pipeline Review, H1 2014', provides an overview of the Seizures's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Seizures,...

2014-06-30 08:31:21

First Branded Product in CNS Portfolio Now Available MAPLE GROVE, Minn., June 30, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced that Qudexy(TM) XR (topiramate) extended-release capsules is now available to patients in the United States. Qudexy(TM) XR is a once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth pharmacokinetic (PK) profile. It was approved by the U.S. Food and Drug Administration in March 2014...

2014-06-17 08:26:35

Recently FDA Approved Qudexy(TM) XR Offers a New Treatment Option for Managing Specific Seizure Types MAPLE GROVE, Minn., June 17, 2014 /PRNewswire/ -- Results from Upsher-Smith Laboratories, Inc.'s, Phase 3 study of USL255, Qudexy(TM) XR (topiramate) extended-release capsules, a proprietary, once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth pharmacokinetic (PK) profile, were published in the June issue of Epilepsia, a leading, authoritative...

2014-06-10 16:27:34

For people who don't respond to medications, SEEG pinpoints and eliminates exact source of seizures in brains CHICAGO, June 10, 2014 /PRNewswire-USNewswire/ -- For the more than 2 million Americans living with epilepsy, managing seizures is the key to living a normal life. And for many, medications do just that - allowing them to drive, have jobs and raise families. But for almost one-third of epileptics, medicine is not enough. Specialists at Northwestern Medicine's Comprehensive...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related